Findings

What do systematic reviews say?

9 questions · 9 findings · 8 reviews

No studies found 5 · 55.6%GRADE not reported 1 · 11.1%Very low 2 · 22.2%Low 0 · 0%Moderate 1 · 11.1%High 0 · 0%

Quality of life · cancer patients

The review found no eligible studies for this question.

1 finding from 1 review

Olanzapine for the prevention and treatment of cancer‐related nausea and vomiting in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Quality of life · cancer patients

The review found no eligible studies for this question.

1 finding from 1 review

Olanzapine for the prevention and treatment of cancer‐related nausea and vomiting in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Quality of life not reported · patients with sexual dysfunction due to antipsychotic drug therapy

The review found no eligible studies for this question.

1 finding from 1 review

Management of sexual dysfunction due to antipsychotic drug therapy 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Quality of life ‐ not measured · treatment‐resistant depression in adults

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for treatment‐resistant depression in adults 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Quality of life: as · patients with schizophrenia

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 68 participants
Very low

Quality of life (long term) ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Fluphenazine (oral) versus atypical antipsychotics for schizophrenia 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Quality of life (medium term: 12 months) · schizophrenia

1 finding from 1 review

Quetiapine versus other atypical antipsychotics for schizophrenia 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 286 participants
Moderate

Health‐related quality of life (physical) · patients with schizophrenia

1 finding from 1 review

Chlorpromazine versus atypical antipsychotic drugs for schizophrenia 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 61 participants
Very low